Effects of Helicobacter pylori infection on genetic instability, the aberrant CpG island methylation status and the cellular phenotype in Barrett's esophagus in a Japanese population

International Journal of Cancer

Volumn 124, Issue 6, 2009, Pages 1263-1269

  Moriichi, Kentaro ^a   Watari, Jiro ^a   Das, Kiron M ^b   Tanabe, Hiroki ^a   Mikihiro, Fujiya ^a   Ashida, Toshifumi ^a   Kohgo, Yutaka ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Barrett's esophagus; CpG island methylation; Genetic instability; Helicobacter pylori; Specialized intestinal metaplasia

Indexed keywords

AMOXICILLIN; APC PROTEIN; BIOLOGICAL MARKER; CLARITHROMYCIN; LANSOPRAZOLE; PROTEIN MLH1; PROTEIN P16; UVOMORULIN; CADHERIN; DNA; MICROSATELLITE DNA; MLH1 PROTEIN, HUMAN; NUCLEAR PROTEIN; PRIMER DNA; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; ERADICATION THERAPY; FEMALE; GENETIC INSTABILITY; GENETIC PARAMETERS; GENETIC VARIABILITY; HELICOBACTER INFECTION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INTESTINE METAPLASIA; JAPANESE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; DNA REPAIR; GENETICS; HELICOBACTER PYLORI; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; JAPAN; MIDDLE AGED; PATHOLOGY; TUMOR SUPPRESSOR GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; BARRETT ESOPHAGUS; CADHERINS; CPG ISLANDS; DNA; DNA METHYLATION; DNA PRIMERS; DNA REPAIR; FEMALE; GENES, APC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINAL MUCOSA; JAPAN; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE INSTABILITY; MICROSATELLITE REPEATS; MIDDLE AGED; NUCLEAR PROTEINS; PHENOTYPE; POLYMERASE CHAIN REACTION;

EID: 60549100924     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24092     Document Type: Article

References (45)

1. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000;119:333 - 8.
2. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF, Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287 - 9.
3. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049 - 53.
4. Hongo M. Review article: Barrett's oesophagus and carcinoma in Japan. Aliment Pharm Ther 2004;20 Suppl 8:50 - 4.
5. Prach AT, MacDonald TA, Hopwood DA, Johnston DA. Increasing incidence of Barrett's oesophagus: education, enthusiasm or epidemiology? Lancet 1997;350:933.
6. Chen YY, Antonioli DA, Spechler SJ, Zeroogian JM, Goyal RK, Wang HH. Gastroesophageal reflux disease versus Helicobacter pylori infection as the cause of gastric carditis. Mod Pathol 1998;11:950 - 6.
7. Genta RM, Huberman RM, Graham DY. The gastric cardia in Helicobacter pylori infection. Hum Pathol 1994;25:915 - 9.
8. Goldblum JR, Vicari JJ, Falk GW, Rice TW, Peek RM, Easley K, Richter JE. Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. Gastroenterology 1998;114:633 - 9.
9. Hackelsberger A, Günther T, Schultze V, Manes G, Dominguez- Muñoz JE, Roessner A, Malfertheiner P. Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastrooesophageal reflux disease? Gut 1998;43:17 - 21.
10. Oberg S, Peters JH, DeMeester TR, Chandrasoma P, Hagen JA, Ireland AP, Ritter MP, Mason RJ, Crookes P, Bremner CG. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg 1997;226:522 - 32.
11. Spechler SJ. The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology 1999;117:218 - 28.
12. Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol Hepatol 2007;5:1413 - 7.
13. Anderson LA, Murphy SJ, Johnston BT, Watson RG, Ferguson HR, Bamford KB, Ghazy A, McCarron P, McGuigan J, Reynolds JV, Comber H, Murray LJ. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut 2008;57:734 - 9.
14. Richter JE, Falk GW, Vaezi MF. Helicobacter pylori and gastroesophageal reflux disease: the bug may not be all bad. Am J Gastroenterol 1998;93:1800 - 2.
15. Ye W, Held M, Lagergren J, Engstrand L, Blot WJ, McLaughlin JK, Nyrén O. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst 2004;96:388 - 96.
16. Aldulaimi D, Jankowski J. Barrett's esophagus: an overview of the molecular biology. Dis Esophagus 1999;12:177 - 80.
17. Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Russell SE. Base transitions at CpG dinucleotides in the p53 gene are common in esophageal adenocarcinoma. Cancer Res 1995;55:3406 - 11.
18. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003;349:2042 - 54.
19. Jones PA, Buckley JD. The role of DNA methylation in cancer. Adv Cancer Res 1990;54:1 - 23.
20. Jankowski JA, Harrison RF, Perry I, Balkwill F, Tselepis C. Barrett's metaplasia. Lancet 2000;356:2079 - 85.
21. Wijnhoven BP, Tilanus HW, Dinjens WN. Molecular biology of Barrett's adenocarcinoma. Ann Surg 2001;233:322 - 37.
22. Chan AO, Peng JZ, Lam SK, Lai KC, Yuen MF, Cheung HK, Kwong YL, Rashid A, Chan CK, Wong BC. Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut 2006;55:463 - 8.
23. Leung WK, Man EP, Yu J, Go MY, To KF, Yamaoka Y, Cheng VY, Ng EK, Sung JJ. Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. Clin Cancer Res 2006;12:3216 - 21.
24. Perri F, Cotugno R, Piepoli A, Merla A, Quitadamo M, Gentile A, Pilotto A, Annese V, Andriulli A. Aberrant DNA methylation in nonneoplastic gastric mucosa of H. Pylori infected patients and effect of eradication. Am J Gastroenterol 2007;102:1361 - 71.
25. Das KM, Prasad I, Garla S, Amenta PS. Detection of a shared colon epithelial epitope on Barrett epithelium by a novel monoclonal antibody. Ann Intern Med 1994;120:753 - 6.
26. Griffel LH, Amenta PS, Das KM. Use of a novel monoclonal antibody in diagnosis of Barrett's esophagus. Dig Dis Sci 2000;45:40 - 8.
27. Onuma EK, Amenta PS, Jukkola AF, Mohan V, Borra S, Das KM. A phenotypic change of small intestinal epithelium to that of colonocytes in small intestinal adenomas and adenocarcinomas. Am J Gastroenterol 2001;96:2480 - 5.
28. Mirza ZK, Das KK, Slate J, Mapitigama RN, Amenta PS, Griffel LH, Ramsundar L, Watari J, Tokota K, Tanabe H, Sato T, Kohgo Y, et al. Gastric intestinal metaplasia as detected by a novel biomarker is highly associated with gastric adenocarcinoma. Gut 2003;52:807 - 12.
29. Watari J, Das KK, Amenta PS, Tanabe H, Tanaka A, Geng X, Lin JJ, Kohgo Y, Das KM. Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia. Clin Gastroenterol Hepatol 2008;6:409 - 19.
30. Goda K, Tajiri H, Ikegami M, Urashima M, Nakayoshi T, Kaise M. Usefulness of magnifying endoscopy with narrow band imaging for the detection of specialized intestinal metaplasia in columnar-lined esophagus and Barrett's adenocarcinoma. Gastrointest Endosc 2007; 65:36 - 46.
31. Tanaka A, Watari J, Tanabe H, Fujiya M, Ashida T, Das KM, Kohgo Y. Effect of eradication of Helicobacter pylori on genetic instabilities in gastric intestinal metaplasia. Aliment Pharmacol Ther 2006;24(Suppl 4):194 - 202.
32. Shibata N, Watari J, Fujiya M, Tanno S, Sayito Y, Kohgo Y. Cell kinetic and genetic instabilities in differentiated type early gastric cancers with different mucin phenotype. Hum Pathol 2003;34:32 - 40.
33. Zaky A, Watari J, Tanabe H, Sato R, Moriichi K, Tanaka A, Maremoto A, Fujiya M, Ashida T, Kohgo Y. Clinicopathological implications of genetic instability in intestinal type gastric cancer and intestinal metaplasia as a precancerous lesion: proof of field cancerization in the stomach. Am J Clin Pathol 2008;129:613 - 21.
34. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S. National cancer institute on workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248 - 57.
35. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. Methylation- specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821 - 6.
36. Szantai E, Ronai Z, Sasvari-Szekely M, Bonn G, Guttman A. Multicapillary electrophoresis analysis of single-nucleotide sequence variations in the deoxycytidine kinase gene. Clin Chem 2006;52:1756 - 62.
37. Romagnoli S, Roncalli M, Graziani D, Cassani B, Roz E, Bonavina L, Peracchia A, Bosari S, Coggi G. Molecular alterations of Barrett's esophagus on microdissected endoscopic biopsies. Lab Invest 2001;81:241 - 7.
38. Meltzer SJ, Yin J, Manin B, Rhyu MG, Cottrell J, Hudson E, Redd JL, Krasna MJ, Abraham JM, Reid BJ. Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett's-associated esophageal adenocarcinomas. Cancer Res 1994;54:3379 - 82.
39. Moriichi K, Watari J, Das KM, Tanabe H, Sato R, Zaky AH, Konno Y, Ishikawa C, Inaba Y, Okamoto K, Maemoto A, Fujiya M, et al. Effects of Helicobacter pylori infection on genetic instability, aberrant CpG island methylation status and cellular phenotype in intestinal metaplasia of Barrett's esophagus in Japanese population: a prospective follow-up study after eradication. Gastroenterology 2008;134: A438.
40. Swami S, Kumble S, Triadafilopoulos G. E-cadherin expression in gastroesophageal reflux disease. Barrett's esophagus, and esophageal adenocarcinoma: an immunohistochemical and immunoblot study. Am J Gastroenterol 1995;90:1808 - 13.
41. Bailey T, Biddlestone L, Shepherd N, Barr H, Warner P, Jankowski J. Altered cadherin and catenin complexes in the Barrett's esophagusdysplasia- adenocarcinoma sequence: correlation with disease progression and dedifferentiation. Am J Pathol 1998;152:135 - 44.
42. Eads CA, Lord RV, Kurumboor SK, Wickramasinghe K, Skinner ML, Long TI, Peters JH, DeMeester TR, Danenberg KD, Danenberg PV, Laird PW, Skinner KA. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res 2000;60:5021 - 6.
43. Bongiorno PF, al-Kasspooles M, Lee SW, Rachwal WJ, Moore JH, Whyte RI, Orringer MB, Beer DG. E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus. Br J Cancer 1995;71:166 - 72.
44. Wong DJ, Paulson TG, Prevo LJ, Galipeau PC, Longton G, Blount PL, Reid BJ. p16 (INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Res 2001;61:8284 - 9.
45. Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 2001; 61:3573 - 7.